Intermittent Hypoxic Treatment (IHT), also known as Intermittent Hypoxic-Hyperoxic Training (IHHT), is a therapeutic technique that involves alternating between breathing oxygen-reduced air (hypoxia) and ambient or oxygen-enriched air (hyperoxia). This process mimics the physiological effects of high-altitude training and is believed to stimulate a range of beneficial cellular and systemic adaptations.

Science and general applications

Evidence-based research and clinical studies suggest that IHT may have therapeutic potential for a number of conditions. It’s important to note that the effectiveness and safety of IHT are highly dependent on the specific protocol used, including the severity and duration of hypoxia, the number of cycles, and the overall duration of the treatment. “Low dose” IHT (modest hypoxia with a low number of cycles) is more consistently associated with beneficial effects, while severe or prolonged hypoxia can be damaging. The physiological response to hypoxia is dose-dependent, meaning the severity and duration of exposure can be either beneficial or harmful. This fundamental concept is critical for understanding why a controlled, short-term hypoxic challenge is a safe and effective diagnostic tool, while chronic or severe hypoxia (such as in sleep apnea) can be detrimental. It provides a solid scientific basis for why IHT is used in a clinical setting.

Evidence-based applications of Intermittent Hypoxic Treatment:

Cardiovascular and Metabolic Health:

• Hypertension and Cardiovascular Disease: IHT has been shown to reduce blood pressure, improve heart rate, and enhance the resistance of the heart and brain to acute ischemia (lack of blood flow). It may also improve circulation by increasing the production of nitric oxide, which helps to dilate blood vessels.
• Ischemic Stroke: IHT is being investigated as a potential strategy for both preventing and treating ischemic stroke. It may offer neuroprotective effects and promote post-injury repair and regeneration.
• Obesity and Metabolic Syndrome: Some studies suggest that IHT can help with weight management by decreasing fat mass and improving the body’s ability to break down carbohydrates and control blood sugar levels.

Respiratory Conditions:

• Chronic Obstructive Pulmonary Disease (COPD) and Bronchial Asthma: Clinical experience suggests that IHT can significantly improve the clinical picture of these conditions, leading to a reduction in symptoms like shortness of breath and cough. It may also increase exercise tolerance in patients with mild COPD.

Neurological and Cognitive Function:

• Stroke Rehabilitation: In a small case series, acute intermittent hypoxia was found to be well-tolerated and showed potential for improving strength and limb function in people with chronic hemiparetic stroke.
• Cognitive Performance: IHT has been linked to improvements in concentration, mental function, and overall cognitive performance.

Other Applications:

• Aging: IHT may be a useful therapeutic tool to address age-related issues such as increased body fat, loss of bone mass, and low-grade inflammation.
• Sleep Quality: Some research indicates that IHT can improve sleep quality and help those suffering from insomnia.
• Athletic Performance and Recovery: This is one of the most well-known applications of IHT. It is used to improve endurance, speed, and power output, as well as to enhance recovery from physical exertion by increasing oxygen transport and mitochondrial efficiency.
• Chronic Fatigue and Energy Levels: By optimizing cellular energy production and mitochondrial function, IHT is believed to combat the effects of chronic fatigue and improve overall energy levels.
• Depression and Anxiety: IHT may help to alleviate symptoms of depression and anxiety by influencing the nervous system and improving overall well-being.
• Immune Function: The therapy is thought to boost the immune system and increase the body’s resilience to illness.

A typical session of Intermittent Hypoxic Training (IHT) involves alternating between breathing oxygen-reduced air and normal air. The specific duration, cycles, and frequency can vary widely depending on the individual’s goals, fitness level, and the specific protocol being used.

How a Session Works

IHT is performed using a specialized device called a hypoxicator, which delivers a gas mixture with a lower-than-normal oxygen concentration (simulating high altitude) through a mask. A session is typically broken down into repeated cycles of hypoxic exposure and normoxic recovery.

Key Components:

• Hypoxic Exposure: This is the “on” cycle where you breathe low-oxygen air, typically lasting anywhere from 3 to 10 minutes. The simulated altitude can range from 2,500 to 6,500 meters (about 8,200 to 21,300 feet), with oxygen levels between 9.5% and 16%. During this period, your body is stressed by the reduced oxygen availability.
• Normoxic Recovery: This is the “off” cycle where you remove the mask and breathe normal, ambient air. This recovery period allows your blood oxygen saturation levels to return to normal. These periods are often of similar duration to the hypoxic cycles (e.g., 5 minutes on, 5 minutes off).

Session Duration and Frequency:

• A full IHT session usually lasts between 30 and 60 minutes.
• Within this session, you’ll complete a series of 3 to 15 cycles of hypoxic and normoxic breathing.
• Protocols vary, but a common approach is to perform 2 to 3 sessions per week for a period of several weeks.

Different Types of IHT

IHT can be done in two main ways: while at rest or during exercise.

1. Hypoxic Training at Rest (Intermittent Hypoxic Exposure or IHE)

This is often used for general health and wellness, or for acclimatization purposes. The person remains stationary (e.g., sitting or relaxing) while undergoing the cycles. The person either wears a mask or is sitting inside a tent without a mask This method is less strenuous and focuses on eliciting physiological adaptations without the added stress of physical exertion.

2. Hypoxic Training during Exercise (Intermittent Hypoxic Training or IHT)

This method is more common for athletes. The individual performs a high-intensity workout (e.g., cycling, running) while breathing the low-oxygen air. This amplifies the physiological stress, as the body must work harder to supply oxygen to the muscles. The workouts are typically structured as interval training, with high-intensity bouts in hypoxia followed by recovery periods. Once again, either the person wears a mask or is sitting inside a tent without a mask.

Regardless of the method, a pulse oximeter is often used to monitor blood oxygen saturation and heart rate, ensuring the session is both safe and effective.

Important Considerations and Caveats:

• The research on IHT is still evolving, and many studies, particularly older ones, may have been published in languages other than English, limiting their accessibility.
• The effectiveness of IHT is highly dependent on the “dose” of hypoxia. Severe or prolonged hypoxic exposure can be detrimental, while a moderate, controlled regimen is more likely to be beneficial.
• IHT should be performed under professional supervision, with careful monitoring of blood oxygen saturation, heart rate, and blood pressure to ensure safety.
• Certain conditions, such as poorly controlled cardiac and respiratory problems, acute infections with fever, epilepsy, and decompensated chronic diseases, are often considered contraindications for IHT.

Review of scientific literature, including systematic reviews, meta-analyses, and clinical trials.

It’s important to remember that IHT is a therapeutic modality and should be performed under the guidance of a qualified healthcare professional. The specific protocols (e.g., duration, oxygen concentration, number of cycles) are crucial and can determine whether the effects are beneficial or potentially harmful.

1. Cardiovascular and Metabolic Health

• Hypertension and Cardiovascular Disease: IHT, particularly with alternating hypoxia and hyperoxia (IHHT), has been shown to be safe and effective in reducing blood pressure in patients with cardiovascular diseases. It can also improve exercise tolerance and overall cardiovascular function.
• Reference: Burtscher, M., Gatterer, H., & Müller, M. (2022). Safety and Efficacy of Intermittent Hypoxia Conditioning as a New Rehabilitation/Secondary Prevention Strategy for Patients with Cardiovascular Diseases: A Systematic Review and Meta-analysis. International Journal of Environmental Research and Public Health, 19(6), 3328. PMID: 35329188
• Reference: Kujovská-Bártová, V., & Serebrovskaya, T. V. (2021). Mild Intermittent Hypoxia: A New Treatment Approach for Patients with Obstructive Sleep Apnea and Hypertension. American Journal of Respiratory and Critical Care Medicine, 205(8), 959–960. PMCID: PMC9954325
• Metabolic Syndrome and Obesity: Research suggests that IHT can improve lipid profiles (e.g., lower total cholesterol and triglycerides) and reduce inflammatory markers in patients with metabolic syndrome. It may also improve liver and renal function in obese patients.
• Reference: Dzhagarov, M. V., et al. (2021). The Effects of Intermittent Hypoxic–Hyperoxic Exposures on Lipid Profile and Inflammation in Patients With Metabolic Syndrome. Frontiers in Physiology, 12, 730628. PMCID: PMC8429814
• Reference: Iliescu, M. (2023). The Impact of Intermittent Hypoxia-Hyperoxia Therapy on Metabolism and Respiratory System in Obese Patients as Part of Comprehensive Medical Rehabilitation. Cureus, 15(11), e49725. PMID: 39544552

• 2. Neurological Conditions and Rehabilitation

• Spinal Cord Injury (SCI): Acute intermittent hypoxia (AIH) has been shown to improve gait and motor function in individuals with incomplete SCI. The effects are thought to be mediated by beneficial neuroplasticity.
• Reference: Al-Baroud, A. et al. (2025). Acute intermittent hypoxia in spinal cord injury gait rehabilitation: a systematic review of randomized trials. Journal of NeuroEngineering and Rehabilitation, 22(1), 10. PMID: 39836239
• Reference: Mateika, J. H., & Komnenov, D. (2017). Intermittent hypoxia initiated plasticity in humans: a multipronged therapeutic approach to treat sleep apnea and overlapping co-morbidities. Experimental Neurology, 287(Pt 1), 113–129. PMID: 27198751
• Brain Injury and Neurodegeneration: Intermittent hypoxic conditioning (IHC) may have a neuroprotective effect. Studies in animal models suggest that it can promote neurogenesis and suppress inflammation, which are beneficial for restoring neurological function after brain injury.
• Reference: Li, G., et al. (2023). Intermittent hypoxic conditioning restores neurological dysfunction of mice induced by long‐term hypoxia. CNS Neuroscience & Therapeutics, 29(1), 202-215. PMCID: PMC9804074

• 3. Respiratory Conditions

• Chronic Obstructive Pulmonary Disease (COPD): Studies have shown that IHT can improve exercise tolerance in patients with mild COPD. It’s considered a potential non-pharmacological therapy that can improve symptoms and quality of life.
• Reference: Vgontzas, A. N., et al. (2009). Intermittent hypoxia increases exercise tolerance in patients at risk for or with mild COPD. Respiratory Physiology & Neurobiology, 165(1), 97–103. PMID: 19013544

• 4. Athletic Performance and General Well-being

• Aerobic Capacity and Exercise Performance: IHT is widely used to improve the aerobic capacity of athletes. Meta-analyses have shown that it can significantly increase maximal oxygen uptake (VO_2max) and hemoglobin levels.
• Reference: Wang, F., et al. (2023). The effects of intermittent hypoxic training on the aerobic capacity of exercisers: a systemic review and meta-analysis. Environmental Health and Preventive Medicine, 28(1), 86. PMCID: PMC10731756
• General Health and Adaptation: Mild IHT is considered a safe and effective method to enhance the body’s overall adaptive potential and increase resistance to various stressors.
• Reference: Serebrovskaya, T. V., & Nizhnik, O. (2022). Intermittent Hypoxic Training as an Effective Tool for Increasing the Adaptive Potential, Endurance and Working Capacity of the Brain. International Journal of Molecular Sciences, 23(13), 7384. PMCID: PMC9254677

This is not an exhaustive list, but it highlights some of the key areas where IHT has shown promise based on scientific evidence published in peer-reviewed journals. More research is ongoing to fully understand the mechanisms and optimize the therapeutic protocols for different conditions.